Skip to main content
. Author manuscript; available in PMC: 2009 Sep 17.
Published in final edited form as: Pediatr Radiol. 2008 Mar 21;38(5):529–537. doi: 10.1007/s00247-008-0764-6

Figure 2.

Figure 2

FR-targeted gadolinium MR contrast agent P866 (A), and FR-targeted iron-oxide MR contrast agent P1048 (B). P866 is a high relaxivity dimeric gadolinium chelate conjugated to folate. P1048 consists of an iron-oxide core conjugated to folate.